Search

Streptococcus parauberis is an etiological agent that causes streptococcosis in fish, exerting a significant impact on aquaculture production. The available injectable vaccine against S. parauberis is commonly used in olive flounder species (Paralichthys olivaceus) in Korea. However, an oral alternative that overcomes the disadvantages of the injectable vaccine has long been desired in the aquaculture industry. Alginate-based microparticles have been widely used as delivery systems for oral administration in aquaculture. In the present study, we produced alginate microparticles encapsulating formalin-inactivated S. parauberis via ionic gelation, which remained stable under acidic conditions (pH 2 and 4) and at low temperatures (4 °C and 25 °C). Mixing the alginate–Gelzan complex with a commercial feed for ease of application induced a specific antibody response and exerted significant protective effects (relative survival rate: 50.0%) in small olive flounder fingerlings. Less pronounced protective effects were also observed in large fingerlings (relative survival rate: 37.5%), suggesting that protection against S. parauberis may be dependent on the size of the fish. Thus, our results indicate that alginate microparticles encapsulating an S. parauberis antigen can be used for initial vaccination in olive flounder at the fingerling stage. [ABSTRACT FROM AUTHOR]

Streptococcus parauberis , a gram-positive cocci, causes bacterial disease in farmed fish. The recent increase in S. parauberis infection in aquatic farms in South Korea has justified the importance of vaccine development for the prevention of this disease. In this study, we evaluated the effect of subunit vaccines prepared from recombinant M-like protein (SimA) and fibrinogen-binding protein (FBP) candidates with an aluminum hydroxide adjuvant against S. parauberis infection in olive flounder Paralichthys olivaceus. For the in vivo experiment, fish (average length, 7.18 cm; average weight, 3.5 g) were injected intraperitoneally with: phosphate buffer saline (PBS, group 1), PBS/aluminum hydroxide (group 2), FBP/aluminum hydroxide (group 3), SimA/aluminum hydroxide (group 4), and SimA/FBP/aluminum hydroxide (group 5). After 3 weeks, the fish in each group were boosted using PBS (group 1 and 2), FBP (group 3), SimA (group 4), and SimA/FBP (group 5) without adjuvant. We found that the relative percent survival of fish after S. parauberis exposure in group 2, 3, 4, and 5 was 6.25%, 18.75%, 50%, and 12.5%, respectively, whereas the mortality in groups 1 was 80%, respectively. We performed Western blot, ELISA, and quantitative real time RT-PCR (qRT-PCR) after vaccination to investigate the further efficacy of the vaccine. Western blot and ELISA of vaccinated fish serum confirmed the production of specific antibodies against SimA and FBP. Furthermore, results of qRT-PCR showed that recombinant protein SimA induced a remarkably specific-antibody response compared with that in FBP or control and increased the expression of various immune response-related genes including interleukin-8 (IL-8), toll-like receptor 2 (TLR2), tumor necrosis factor-α (TNF-α), CD4-1, and MHC II. Thus, these results indicate that SimA is a potent vaccine candidate for protection against S. parauberis infection. • SimA based vaccine against Streptococcus parauberis in fish prevents infection. • Aluminum hydroxide serves as an effective adjuvant. • SimA/adjuvant-vaccinated fish showed extended survival rate. • In addition expressed immune response-related genes and elevated antibody titer. [ABSTRACT FROM AUTHOR]

• ANK-based DNA vaccine induced a protective immunity in RBIV-infected rock bream. • ANK gene expression displayed a correlation with fish mortality. • TLR3, TLR9, MyD88, Mx, ISG15, PKR, MHC class I, perforin, Fas, Fas ligand and caspases were highly expressed in ANK-based vaccinated group. • IL1β, IL8 and TNFα were not enhanced in ANK-based vaccinated group. Rock bream iridovirus (RBIV) causes severe mass mortalities in rock bream (Oplegnathus fasciatus) and remains an unsolved problem in Korea aquaculture industry. In this study, we assessed the potential of ankyrin repeat (ANK)-containing proteins to induce protective immunity in RBIV-infected rock bream. Rock bream administered with ankyrin repeat-containing protein-based DNA vaccine (200 ng/fish) exhibited significant protection against at 4 and 8 weeks post vaccination to infected with 6.7 × 105 RBIV at 23°C; relative percent survival (RPS) of 60.04% and 40.1%, respectively. Furthermore, survivors from the first infection were strongly protected from RBIV (1.1 × 107) re-infection at 70 days post infection, as 100% RPS was observed and without clinical signs of RBIV diseases. Moreover, TLR3 (9.5-fold), TLR9 (5.2-fold), MyD88 (15.9-fold), Mx (55.5-fold), ISG15 (19.0-fold), PKR (24.2-fold), MHC class I (5.1-fold), perforin (6.5-fold), Fas (6.4-fold), Fas ligand (7.1-fold), caspase8 (5.0-fold), caspase9 (12.5-fold), and caspase3 (6.3-fold) responses were significantly elevated in the muscle (vaccine injection site) of ANK-based DNA vaccinated fish at 7 days post vaccination. However, inflammatory cytokines (IL1β, IL8, and TNFα) were not enhanced in the vaccinated rock bream. Moreover, ANK gene may be a good candidate to detect RBIV infection or in revealing specific information to elucidate the pathogenic mechanisms underlying RBIV infection. In summary, ANK-based DNA vaccination in rock bream induced TLR- and IFN-mediated or apoptosis-related immune responses and suggest efficient preventive measures against RBIV. [ABSTRACT FROM AUTHOR]